AIC
PJP icon

Ameritas Investment Company’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Ameritas Investment Company’s Portfolio PJP Stock Details PJP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-214
Closed -$16.9K – 1710
2021
Q1 		$16.9K Buy
+214
New +$16.7K ﹤0.01% 1356
2020
Q2 		– Sell
-100
Closed -$6K – 1250
2020
Q1 		$6K Buy
+100
New +$6.09K ﹤0.01% 1334
2019
Q2 		– Sell
-670
Closed -$44K – 687
2019
Q1 		$44K Buy
+670
New +$44K 0.01% 446

Other funds holding PJP

PAM
Peak Asset Management Louisville, Colorado $567M AUM 16.44% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Ameritas Investment Company's PJP Position: Q2 2021 in Review

Ameritas Investment Company sold out of Invesco Pharmaceuticals ETF (PJP) in Q2 2021, closing a stake of 214 shares — an estimated $16.9K sold.

Ameritas Investment Company first reported a position in PJP in Q1 2019 and held it in 3 quarters. The position peaked at $44K in Q1 2019. 90 funds tracked by Wall St. Rank hold PJP as of Q2 2021.

  • Ameritas Investment Company reported no remaining Invesco Pharmaceuticals ETF position as of Q2 2021 after selling out during the quarter.
  • Ameritas Investment Company sold 214 Invesco Pharmaceuticals ETF shares in Q2 2021, an estimated $16.9K.
  • Ameritas Investment Company first reported a position in Invesco Pharmaceuticals ETF in Q1 2019 and held it in 3 quarters.
  • Ameritas Investment Company's Invesco Pharmaceuticals ETF position peaked at $44K in Q1 2019.
  • 90 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q2 2021.

Based on Ameritas Investment Company's 13F filing for Q2 2021, filed 16 Aug 2021.